Global Epidemiology of Ischemic Heart Disease: Results from the Global Burden of Disease Study

BackgroundIschemic heart disease (IHD) is a leading cause of death worldwide. Also referred to as coronary artery disease (CAD) and atherosclerotic cardiovascular disease (ACD), it manifests clinically as myocardial infarction and ischemic cardiomyopathy. This study aims to evaluate the epidemiologi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Curēus (Palo Alto, CA) Jg. 12; H. 7; S. e9349
Hauptverfasser: Khan, Moien AB, Hashim, Muhammad Jawad, Mustafa, Halla, Baniyas, May Yousif, Al Suwaidi, Shaikha Khalid Buti Mohamad, AlKatheeri, Rana, Alblooshi, Fatmah Mohamed Khalfan, Almatrooshi, Meera Eisa Ali Hassan, Alzaabi, Mariam Eisa Hazeem, Al Darmaki, Reem Saif, Lootah, Shamsa Nasser Ali Hussain
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Palo Alto Springer Nature B.V 23.07.2020
Cureus
Schlagworte:
Age
Aging
Atherosclerosis
Cardiology
Cardiovascular disease
Data analysis
Data collection
Datasets
Disability
Epidemiology
Epidemiology/Public Health
Estimates
Expenditures
Heart
Ischemia
Metabolism
Methods
Mortality
Population
Preventive Medicine
Risk factors
Trends
United States > US
Asia
Europe
Africa
ISSN:2168-8184, 2168-8184
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:BackgroundIschemic heart disease (IHD) is a leading cause of death worldwide. Also referred to as coronary artery disease (CAD) and atherosclerotic cardiovascular disease (ACD), it manifests clinically as myocardial infarction and ischemic cardiomyopathy. This study aims to evaluate the epidemiological trends of IHD globally.MethodsThe most up-to-date epidemiological data from the Global Burden of Disease (GBD) dataset were analyzed. GBD collates data from a large number of sources, including research studies, hospital registries, and government reports. This dataset includes annual figures from 1990 to 2017 for IHD in all countries and regions. We analyzed the incidence, prevalence, and disability-adjusted life years (DALY) for IHD. Forecasting for the next two decades was conducted using the Statistical Package for the Social Sciences (SPSS) Time Series Modeler (IBM Corp., Armonk, NY).ResultsOur study estimated that globally, IHD affects around 126 million individuals (1,655 per 100,000), which is approximately 1.72% of the world’s population. Nine million deaths were caused by IHD globally. Men were more commonly affected than women, and incidence typically started in the fourth decade and increased with age. The global prevalence of IHD is rising. We estimated that the current prevalence rate of 1,655 per 100,000 population is expected to exceed 1,845 by the year 2030. Eastern European countries are sustaining the highest prevalence. Age-standardized rates, which remove the effect of population changes over time, have decreased in many regions.ConclusionsIHD is the number one cause of death, disability, and human suffering globally. Age-adjusted rates show a promising decrease. However, health systems have to manage an increasing number of cases due to population aging.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:2168-8184
2168-8184
DOI:10.7759/cureus.9349